4//SEC Filing
Greenspan Ira Scott 4
Accession 0001104659-21-109182
CIK 0001772028other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 8:15 AM ET
Size
7.2 KB
Accession
0001104659-21-109182
Insider Transaction Report
Form 4
Greenspan Ira Scott
Director
Transactions
- Purchase
Common Stock, par value $0.001
2021-08-24$4.65/sh+50$233→ 82,340 total - Purchase
Common Stock, par value $0.001
2021-08-23$4.41/sh+500$2,205→ 82,290 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.38 to $4.45 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.50 to $4.70 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
Documents
Issuer
Scopus BioPharma Inc.
CIK 0001772028
Entity typeother
Related Parties
1- filerCIK 0001449211
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 8:15 AM ET
- Size
- 7.2 KB